Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert

2016112 citationsJournal Articlehybrid Open Access

Authors

James D. Brandt · University of California, Davis

Kenneth Sall · Sall Research Medical Center

Harvey Dubiner · Clayton Eye Center

Robert Benza · Cincinnati Eye Institute

Yair Alster · RxSight (United States)

Gary Walker · Menlo School

Charles P. Semba ·

Abstract

Clinically relevant reduction in mean IOP was observed over 6 months with a bimatoprost ocular insert and seems to be safe and well tolerated. The topically applied bimatoprost insert may provide an alternative to daily eye drops to improve adherence, consistency of delivery, and reduction of elevated IOP.

Topics & Keywords

Glaucoma and retinal disorders Ocular Surface and Contact Lens Retinal Diseases and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmology

Volume 123, Issue 8, pp. 1685-1694

DOI: 10.1016/j.ophtha.2016.04.026

Field-Weighted Citation Impact: 10.04